FEB 07, 2018 7:00 AM PST

Understanding "Recommendation" vs. "Prescription" of Medical Marijuana

WRITTEN BY: Mauri Brueggeman

The US Federal Government has marijuana listed as a Schedule 1 drug, in addition to heroin, lysergic acid diethylamide (LSD), and others considered to have a high potential for abuse and with no medical value (according to the federal government). This classification creates challenges for advancing medical research and use, and therefore increased data analysis of benefits and drawbacks, of medical cannabis in the United States. In addition, the Schedule 1 categorization prohibits the prescription, administration, or direct distribution of these drugs by any doctors in the United States. This categorization is applied regardless of the potency or varieties of low-THC substances or extracts.

Photo Source: 420 MagazineDespite complex factors at play, medical cannabis is becoming more widely accepted, or at least is being considered, as an alternative therapeutic agent for many medical conditions including neurodegenerative diseases, cancer, pain relief, epilepsy, and anxiety including post-traumatic stress disorder (PTSD). As was recently reported by National Public Radio, groups like military veterans are looking at medicinal cannabis as a replacement for the multitude of drugs they are using to treat their symptoms of pain, anxiety, etc. related to their service. Veterans Affairs has provided exiguous support for the exploration of alternative options to opioids and benzodiazepines. Their policy rhetoric continues to revolve around the federal restrictions for medically trained employees of the government prescribing medical marijuana, which veterans are becoming more vocal about trying as an alternative. The distinction is the term “prescription”. Authorized medical professionals (MDs, Dos, NPs, etc.) can only “recommend” medical cannabis to patients or “certify” that a patient has a qualifying condition as a First Amendment right. Wait… what?

Yep. Our highly educated medical experts cannot prescribe medical marijuana. The last court to review the ruling was the Ninth Circuit court of Appeals in 2002. The resulting verdict being that doctors had a first amendment right to recommend a treatment for a patient but could not prescribe or provide marijuana because of its schedule 1 classification. This is not just for the VA but for all medical professionals. Penalties for physicians and other medical professionals who do not follow the laws for controlled substances are steep including loss of DEA registration, thereby losing ability to prescribe any controlled substances.

The Controlled Substances Act (CSA) was enacted in 1970 as part of the Comprehensive Drug Abuse Prevention and Control Act. Per Section 201 of the Act (21 U.S.C. 811), changes to add, delete, or edit a substance on the schedule can be initiated by the Drug Enforcement Agency (DEA) Department of Health and Human Services (DHS), or by petition from an interested party. The drug is investigated by the DEA and collects necessary data; DHS provides scientific and medical evaluations to make a determination for changes in collaboration between the DEA, DHS, and FDA. The ultimate threshold is whether a drug or substance has the potential for abuse. The Act doesn’t define “potential for abuse” so it is up for interpretation by legislators and evaluators.

For now, military veterans will be asked about their use of marijuana as part of their conversations with VA medical providers; however, veterans will need to seek an alternative provider outside of the VA for a recommendation for medical cannabis if it is legal in their state. Currently in the US, 29 states and the District of Columbia have legalized medical cannabis.

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
FEB 25, 2021
Health & Medicine
Marijuana Legalization Link to Fewer Workers' Compensation Claims
FEB 25, 2021
Marijuana Legalization Link to Fewer Workers' Compensation Claims
A new paper produced partially under the auspices of the federal government and published by the National Bureau of Econ ...
MAY 04, 2021
Health & Medicine
Micro-dosing Inhaler Breakthrough for Medical Cannabis
MAY 04, 2021
Micro-dosing Inhaler Breakthrough for Medical Cannabis
In a leap that will eliminate the risks of vaping or smoking, Canada has just approved an Israeli-made inhaler that is a ...
MAY 19, 2021
Cannabis Sciences
DEA Ends the Monopoly on "Research-Grade" Cannabis
MAY 19, 2021
DEA Ends the Monopoly on "Research-Grade" Cannabis
The US Drug Enforcement Administration (DEA) has slipped out an announcement that’s going to have a huge impact on ...
MAY 29, 2021
Health & Medicine
No Uptick in Students of High School Age Using Cannabis
MAY 29, 2021
No Uptick in Students of High School Age Using Cannabis
It’s a startling statistic: In 2019, about 22 percent of students in grades 9–12 reported that illegal drugs ...
JUN 10, 2021
Health & Medicine
Delta-8 THC: A Cause For Concern
JUN 10, 2021
Delta-8 THC: A Cause For Concern
Delta-8 THC is an ingredient in hemp that can get you high like THC but is currently federally legal due to a loophole i ...
JUL 22, 2021
Health & Medicine
Little Evidence That Cannabis Leads to Demotivation in Young People
JUL 22, 2021
Little Evidence That Cannabis Leads to Demotivation in Young People
The “cannabis stoner” may increasingly be recognized as a tired trope, but there is still a lingering percep ...
Loading Comments...